| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ce9572cb248acfb97a5a830251b71af |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D257-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
| filingDate |
1999-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ab6a022e5db9e2b13f5b83077085b3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_088e936c92c83483a4e14803aa3b2606 |
| publicationDate |
2000-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2000229953-A |
| titleOfInvention |
Method for producing 5-halobutyl-1-cyclohexyltetrasol |
| abstract |
PROBLEM TO BE SOLVED: To provide an industrially safe and convenient method for producing 5-halobutyl-1-cyclohexyltetrazole, which is useful as a synthetic intermediate for cilostazol as a therapeutic agent for thrombosis. SOLUTION: As shown in the following formula, N-cyclohexyl-5 is used. 5-Halobutyl-1-cyclohexyltetrasol is prepared by reacting -hydroxy-n-valeramide with a halogenating agent and sodium azide. Embedded image |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7399864-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7026486-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7825251-B2 |
| priorityDate |
1999-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |